Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Broker spotlight - BP, BHP Billiton, Daily Mail & General Trust, QinetiQ, Amur Minerals

Broker spotlight - BP, BHP Billiton, Daily Mail & General Trust, QinetiQ, Amur Minerals

Brokers boosted their target price on BP (LON:BP.) shares this morning after reports that the oil giant has settled claims with its Deepwater Horizon partners over the 2010 oil spill.

Under the agreements, BP will give up its claims against Transocean and Halliburton for their role in the disaster, while they are similarly ending their actions against the FTSE 100 group.

RBC Capital Markets replaced its ‘underweight’ rating with a ‘neutral’ while JP Morgan reckons the shares are now worth 450p, up from its earlier target of 410p.

Investec adjusted its financial forecasts on BHP Billiton (LON:BLT)  to reflect the spin-off of the South32 portfolio.

“The divestment is occurring at an unfortunate time, with many key commodities at prices not seen since 2009,” said Investec analyst Hunter Hillcoat.

As a result, it reckons the new “improved” BHP Billiton is likely to report decade-low earnings in its maiden year. 

“That said, on our commodity price forecasts, we expect ongoing earnings growth to support the credit rating and the progressive dividend policy,” he added.

The broker increased its target price on BHP shares from 1329p to 1383p, and upgraded its rating to ‘hold’ from ‘sell’.

Elsewhere, Barclays lifted its target price on Daily Mail & General Trust (LON:DMGT) shares by 95p to 1065p.

Yesterday the newspaper group said its full-year results will be in line with market expectations.

Revenues from the company's biggest website, the MailOnline, are expected to offset a decline in print sales.

The publisher also expects to reward shareholders with higher than expected earnings per share.

Defence technology specialist QinetiQ (LON:QQ.) beat analyst estimates with a rise in profit.

Today, JP Morgan kept its overweight stance on the company and raised its target price for the shares to 245p from 210p.

Rightmove (LON:RMV) also received an upgrade.  Exane BNP Paribas added 300p onto its target price for the online estate agent's shares.

The broker now reckons they’re worth 3600p. Shares currently trade at 3,250p. 

Among the small caps; American regulators granted ReNeuron’s (LON:RENE) stem cell treatment for a group of rare eye diseases it fast-track status.

Broker Cenkos reiterated its ‘buy’ recommendation and said with the three clinical programmes well underway, there are a number of exciting opportunities for the company.

Amur Minerals  (LON:AMC) shares rocketed today as the nickel producer was awarded a mining licence for its Kun-Manie project in Far East of Russia.

Broker SP Angel said it was great news. “This puts the company in play in Russia and should generate significant interest within the industry as the Kun Maine project is considered to be a world-class nickel / polymetallic project in its scale.”



Register here to be notified of future SAE Company articles

No investment advice: The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use